What Is Raising AbCellera (ABCL) Stock More Than 5% In Premarket Trades?
AbCellera Biologics Inc. (NASDAQ:ABCL) rose 5.07% to $28.0 during premarket trading today. Last trading session, AbCellera stock lost -7.40% to settle at $26.65. ABCL stock ranged from $26.50 to $29.07. The ABCL stock soared on plans to expand the global headquarters. ABCL’s global plan: AbCellera detects antibodies that its partners can develop into drugs to […]